Cell Genesys

Cell Genesys, Inc. Q1 2008 Earnings Call Transcript (at Seeking Alpha)

yahoo.com     May 18, 2008   6 related          

posted on: May 18, 2008 | about stocks: CEGE Q1 2008 Earnings Call Transcript Executives Susan Ferris – IR Stephen Sherwin – Chairman and CEO Sharon Tetlow – SVP and CFO Analysts Joe Patginis – Canaccord Adams Ren Benjamin – Rodman & Renshaw Mark Monane – Needham & Co. Richard Smith – JPMorgan...                    

comments

                   

Cell Genesys, Inc. Q1 2008 Earnings Call Transcript

seekingalpha.com     May 18, 2008          

posted on: May 18, 2008 | about stocks: CEGE Q1 2008 Earnings Call Transcript Executives Susan Ferris – IR Stephen Sherwin – Chairman and CEO Sharon Tetlow – SVP and CFO Analysts Joe Patginis – Canaccord Adams Ren Benjamin – Rodman & Renshaw Mark Monane – Needham & Co. Richard Smith – JPMorgan...                    

comments

                   

Six Significant Gene Therapy Stocks

seekingalpha.com     May 13, 2008   6 related          

Stockerblog submits: Gene therapy is the process of inserting genes into human cells and tissues for the treatment of diseases, including hereditary diseases. The first gene therapy procedure was performed in 1990 on a four-year old girl who was born with severe combined immunodeficiency, a rare...                    

comments

Cell Genesys Snagging $30M to Push Late-Stage GVAX

tmcnet.com     May 12, 2008   4 related          

Cell Genesys Snagging $30M to Push Late-Stage GVAX ... Financings Roundup Cell Genesys Inc. said it expects to raise $30 million from a direct equity offering, the proceeds of which would fund Phase III trials of prostate cancer treatment GVAX and other purposes. The net...                    

comments

Movers roundup: Palomar Medical, Marathon Oil

ibtimes.com     May 3, 2008          

Among the stock activity stories for Friday, May 2, from AP Financial News: NEW YORK (AP) _ Shares of Palomar Medical Technologies Inc. fell to their lowest point since 2004 on Friday, after the company reported a first-quarter loss on lower revenue and a Lazard Capital Market analyst downgraded...                    

comments

Cell Genesys shares rise after company posts narrower 1st-qtr loss than analysts project

canadianbusiness.com     May 2, 2008          

Shares of Cell Genesys Inc. jumped Friday after the biotech company reported a narrower first-quarter than Wall Street expected.The stock ... NEW YORK (AP) - Shares of Cell Genesys Inc. jumped Friday after the biotech company reported a narrower first-quarter than Wall...                    

comments

                   

Cell Genesys to Present at the Leerink Swann Solid Tumors Roundtable Conference

redorbit.com     May 2, 2008   1 related          

Cell Genesys, Inc. (Nasdaq:CEGE) today announced that Robert J. Dow, MBChB, senior vice president and chief medical officer of Cell Genesys, will present a company update at the Leerink Swann Solid Tumors Roundtable Conference in New York City, on Friday, May 9, 2008 at 1:15 p.m. ET.                    

comments

BUYINS.NET: ETH, NCC, ADEP, CBMX, CEGE, DRYS Have Been Added To Naked Short List Today

tmcnet.com     May 1, 2008   23 related          

BUYINS.NET: ETH, NCC, ADEP, CBMX, CEGE, DRYS Have Been Added To Naked Short List Today ... BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list: Ethan Allen Interiors Inc. (NYSE:...                    

comments

                   
tmcnet.com: Welcome to TMCnet.com tmcnet.com

Japan Pharmas' Love for U.S. Biotechs Just Heating Up

tmcnet.com     Apr 25, 2008          

Japan Pharmas' Love for U.S. Biotechs Just Heating Up ... Can biotech save the Japanese pharmaceutical industry? Certainly there's been an interesting love affair taking place lately between Japan's largest pharmaceutical company and the U.S. biotech sector. If you think...                    

comments

Streetinvesting.com: Progressive Following on Cell Genesys, Inc.

tmcnet.com     Apr 24, 2008   20 related          

Streetinvesting.com: Progressive Following on Cell Genesys, Inc. ... Streetinvesting.com has now resumed our progressive Cell Genesys, Inc. (NASDAQ:CEGE) as it opened up $0.03 on below average volume early trading Thursday, April 24, 2008. Cell Genesys, Inc. announced...                    

comments